ALPAT Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vanduvre-lès-Nancy, France.…
Industry Peers
BiotechnologyKey Statistics
About Plant Advanced Technologies (EPA: ALPAT)
›
Plant Advanced Technologies (EPA: ALPAT) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 11 employees.
The shares were at 3.980 EUR on 19 November 2026, down 52.6% over 52 weeks. Its 52-week range is 3.200 EUR to 8.860 EUR: the price is 55.1% below the high and 24.4% above the low.
At a market capitalisation of 4.53M EUR, it trades at 6.6 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a discount of 80% for ALPAT.
Plant Advanced Technologies reports return on equity of 5.8%, an operating margin of -21.1% and revenue down 6.4% year over year.
Its Piotroski F-score is 4 out of 9, an average reading of its financial health.